Results 201 to 210 of about 2,678,121 (354)

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

open access: yesClinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz   +12 more
wiley   +1 more source

Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B

open access: bronze, 2007
Eugene B. Kern   +5 more
openalex   +2 more sources

Smoking-associated Squamous Metaplasia in Olfactory Mucosa of Patients with Chronic Rhinosinusitis [PDF]

open access: green, 2009
Karen K. Yee   +7 more
openalex   +1 more source

Is Verapamil Effective for Treating Patients With Chronic Rhinosinusitis With Nasal Polyps? A Systematic Review

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Objective Identify and summarise the evidence on the efficacy of low‐dose verapamil use for adult patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Methods Two reviewers independently searched the data sources until the 28th of December 2023.
Fangxing Yin   +3 more
wiley   +1 more source

Sleep in disease: inflammation and chronic rhinosinusitis. [PDF]

open access: yesNeurobiol Sleep Circadian Rhythms
Pandrangi VC, Alt JA.
europepmc   +1 more source

Prevalence and Associated Factors of Olfactory and Gustatory Loss in Patients With Nasal Septal Deviation

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Objectives This study aimed to evaluate the olfactory and gustatory functions of patients with nasal septal deviation (NSD) and identify the factors associated with olfactory loss (OL) and gustatory loss (GL). Design and Setting Retrospective data analysis of cohort group. Participants Two‐hundred fourteen adult patients with NSD at a tertiary
Ja‐Yoon Kim   +3 more
wiley   +1 more source

Primary Antibody Deficiency in Patients With Chronic Rhinosinusitis: A Call for Immunologic Evaluation Prior to Biologic Therapy

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Objective Chronic rhinosinusitis (CRS) is prevalent and causes a great negative impact on quality of life. Primary antibody deficiency (PAD) is highly prevalent with CRS compared to the background population. There are efficient treatment options to consider when CRS is a symptom of PAD. The condition seems to be underdiagnosed.
Anita García Petersen   +4 more
wiley   +1 more source

Utilizing Endotypes, Phenotypes, and Inflammatory Markers to Guide Treatment Decisions in Chronic Rhinosinusitis.

open access: yesAnnals of Allergy, Asthma & Immunology, 2020
Anna G. Staudacher   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy